Celcuity’s Revtorpyk Gets FDA Nod, Delivering Strong Results in PIK3CA Wild-Type Breast Cancer
The new treatment, given with fulvestrant with or without palbociclib, nearly quadrupled progression-free survival versus standard therapy.
NOTRELOAD AI
TeraWulf Unaffected by NY Data Center Pause as Needham Reiterates Buy Rating
Despite Hochul’s one-year moratorium on large data centers, Needham sees limited impact on TeraWulf. Focus shifts to Kentucky’s $19B Anthropic deal and existing NY capacity.
"Rumors Are Completely False": Lucid Group Rejects Bankruptcy Reports
The company confirms it has sufficient liquidity well into next year.
Spero Sells Portion of Utebzi Economics for $105M to Fuel SP001 Development
Spero Therapeutics monetizes its Utebzi royalty stream in a $105M non-dilutive financing deal with Healthcare Royalty, extending cash runway to 2H 2029 while funding SP001 development.
Uber in Advanced Talks to Fully Acquire Delivery Hero
The deal would significantly expand Uber’s global food delivery footprint across Europe, Asia, and the Middle East.
Citigroup Beats Expectations With Record Revenue, But Shares Drop on Spending Outlook
Citigroup delivered a decade-high $24.8 billion revenue and raised its dividend, yet shares declined after the CEO signaled continued heavy investment spending.